Eaton Vance Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Eaton Vance Management's RGEN Position: Q3 2022 in Review
Eaton Vance Management reduced its Repligen (RGEN) stake by 29% in Q3 2022, selling an estimated $8.87M and leaving 102,218 shares worth $19.1M. The position accounts for 0.03% of the portfolio, ranked #451.
Eaton Vance Management first reported a position in RGEN in Q2 2017 and has held it in 22 quarters since. The position peaked at $38.1M in Q3 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.
- Eaton Vance Management held 102,218 shares of Repligen worth $19.1M as of Q3 2022.
- Eaton Vance Management sold 42,082 Repligen shares in Q3 2022, an estimated $8.87M.
- Repligen made up 0.03% of Eaton Vance Management's portfolio in Q3 2022, its #451 holding.
- Eaton Vance Management first reported a position in Repligen in Q2 2017 and has held it in 22 quarters since.
- Eaton Vance Management's Repligen position peaked at $38.1M in Q3 2021.
- 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.